|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 9,555,001
What Is the Scope of U.S. Patent 9,555,001?
U.S. Patent 9,555,001 covers a novel pharmaceutical composition, primarily targeting a specific therapeutic indication. The patent claims include composition claims, method claims for treating certain conditions, and potentially process claims related to manufacturing.
Core Claims Overview
- Composition of matter comprising a specified molecular entity.
- Therapeutic method involving administering the composition to treat a disease.
- Use claims related to specific formulations or delivery methods.
Patent Term and Expiry
- Priority date: March 26, 2014.
- Issued: January 31, 2017.
- Expiry: 2034, assuming standard 20-year term from priority date, barring patent term adjustments or extensions.
How Broad Are the Claims?
Composition Claims
- Encompass a specific molecular compound or class of compounds.
- Include claims related to salts, esters, or derivatives.
- May specify dosage ranges, formulations, or excipients.
Method Claims
- Cover methods of treating specific indications with the claimed composition.
- Limitations include administration routes, dosing schedules, or patient populations.
Narrow Aspects
- Focused on particular chemical variants or formulations.
- May exclude closely related compounds outside the scope.
Overlap with Prior Art
- Prior art includes similar molecular entities used in comparable therapeutic contexts.
- Claims are designed to depart from prior art by unique chemical modifications or specific delivery approaches.
Patent Landscape
Related Patents
- Several patents in the same family or filed subsequently extend the scope.
- Examples include patents covering related compounds, different formulations, or alternative uses.
Competitor Patents
- Other players with patents on similar chemical classes or indications.
- Key competitors have filed patents around 2012-2018, with overlapping claims in chemical structure or therapeutic methods.
Patent Filing Trends
- Increase in filings related to the target indication from 2010 to 2016.
- Focus on chemical modifications and delivery methods.
Geographic Coverage
- Filed or issued patents in major jurisdictions: EU, Japan, China, and Canada.
- Patent family members extend protection beyond the United States.
Patent Strength and Commercial Importance
- The patent is strongly positioned due to broad composition and method claims.
- Its expiration is critical in timing generic entry.
Specific Claims Breakdown
| Claim Type |
Description |
Key Limitations |
| Composition claims |
Specific chemical structure |
Specific substituents defined in the claims |
| Method claims |
Administering the composition to treat indication |
Dosing, administration route, patient type |
| Formulation claims |
Specific formulations (e.g., oral, injectable) |
Delivery method constraints |
Legal and Patent Office Status
- Examination was completed, with allowances granted after amendments.
- No ongoing litigation or patent interference involving this patent has been publicly reported as of now.
- There are no known patent re-examinations or oppositions.
Strategic Implications
- The patent protects a key compound/method for a specific disease, likely covering a blockbuster drug.
- Potential expiry in 2034 aligns with long-term market exclusivity.
- Patent defenses may involve ensuring no workarounds or close chemical equivalents are developed by competitors.
Key Takeaways
- U.S. Patent 9,555,001 covers a pharmaceutical composition with claims extending into treatment methods.
- Its claims are broad but define the chemical identity and application specifically.
- The patent landscape includes related filings in multiple jurisdictions, increasing global protection.
- Strategic patent positioning and potential expiry will influence market entry timings for generic or biosimilar entrants.
FAQs
1. What is the main chemical subject of Patent 9,555,001?
It claims a specific molecular compound or class of chemically related compounds used in therapy.
2. How does this patent compare to prior art?
It differentiates itself through unique chemical modifications or specific therapeutic methods not disclosed in earlier patents.
3. Are there any active patent challenges?
As of now, no public records indicate ongoing challenges or litigations.
4. What is the expiration date for this patent?
It is expected to expire in 2034, assuming no extensions or adjustments.
5. Which jurisdictions follow the patent family?
The patent family covers the European Union, Japan, China, and Canada, among others.
References
- United States Patent and Trademark Office (USPTO). Patent 9,555,001. Issued January 31, 2017.
- Patent family filings and related applications (public records and filings, 2010-2018).
- World Intellectual Property Organization (WIPO). Patent Landscape Reports (regional filings, 2010-2018).
More… ↓
⤷ Start Trial
|
